Adeyemi Abayomi MD Chicago, IL - 60617

Adeyemi Abayomi MD is categorized under Business Services (Unclassified) in Chicago, IL and active since 2013.

Adeyemi Abayomi MD was established in 2013, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.

If you are seeking more information, feel free to contact Abayomi Adeyemi at the company’s single location by writing to 9133 South Stony Island Avenue, Chicago, Illinois IL 60617 or by phoning (773) 375-3911. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Adeyemi Abayomi MD
Contact Person: Abayomi Adeyemi
Address: 9133 South Stony Island Avenue, Chicago, Illinois 60617
Phone Number: (773) 375-3911
Website Address: advocatehealth.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2013
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Business Services (Unclassified)
SIC Code: 7389
NAICS Code: 561499
Share This Business:

Adeyemi Abayomi MD was started in 2013 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Abayomi Adeyemi for inquiries that concern Adeyemi Abayomi MD by calling the company number (773) 375-3911, as your correspondence is most welcome. Additionally, the physical location of the single location of Adeyemi Abayomi MD can be found at the coordinates 41.729127,-87.585406 as well as the street address 9133 South Stony Island Avenue in Chicago, Illinois 60617.

For its online presence, you may visit Adeyemi Abayomi MD’s website at advocatehealth.com and engage with its social media outlets through on Twitter and on Facebook.